Literature DB >> 9850913

The prognosis of mild cognitive impairment in the elderly.

H Wolf1, M Grunwald, G M Ecke, D Zedlick, S Bettin, C Dannenberg, J Dietrich, K Eschrich, T Arendt, H J Gertz.   

Abstract

PURPOSE: To determine whether or not subtypes of intellectual functioning are suitable to predict further cognitive decline in individuals with mild cognitive impairment.
DESIGN: Naturalistic longitudinal study (mean interval 2.7 years). PATIENTS: 41 subjects with mild cognitive impairment who attended a memory clinic.
METHODS: SIDAM, CT, SPECT, and ApoE genotype.
RESULTS: At follow-up, 8 out of 41 patients (19.5%) with MCI had progressed to dementia, 8 patients (19.5%) had improved to normal levels of cognitive functioning, 25 patients (61%) had remained stable within the MCI group. At baseline the two prognostic groups differed significantly with regard to age, memory functions, orientation, and the degree of atrophy of the left medial temporal lobe on CT scan.
CONCLUSION: The majority of MCI patients in this study remained cognitively stable within the observation period. Patients with older age, poorer test performance on memory tasks and orientation deficits are at higher risk of progressive decline to dementia. CT measures of medial temporal lobe atrophy may be a sensitive parameter of group discrimination.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9850913     DOI: 10.1007/978-3-7091-7508-8_4

Source DB:  PubMed          Journal:  J Neural Transm Suppl        ISSN: 0303-6995


  14 in total

Review 1.  The impact of mild cognitive impairment on functional abilities in the elderly.

Authors:  Steven M Albert; Matias H Tabert; Alan Dienstag; Gregory Pelton; Devangere Devanand
Journal:  Curr Psychiatry Rep       Date:  2002-02       Impact factor: 5.285

2.  Association of ApoE and LRP mRNA levels with dementia and AD neuropathology.

Authors:  Afia Akram; James Schmeidler; Pavel Katsel; Patrick R Hof; Vahram Haroutunian
Journal:  Neurobiol Aging       Date:  2011-06-15       Impact factor: 4.673

3.  Measurement Equivalence of the Patient Reported Outcomes Measurement Information System® (PROMIS®) Applied Cognition - General Concerns, Short Forms in Ethnically Diverse Groups.

Authors:  Robert Fieo; Katja Ocepek-Welikson; Marjorie Kleinman; Joseph P Eimicke; Paul K Crane; David Cella; Jeanne A Teresi
Journal:  Psychol Test Assess Model       Date:  2016

Review 4.  Recollection and familiarity in aging individuals with mild cognitive impairment and Alzheimer's disease: a literature review.

Authors:  Dorothee Schoemaker; Serge Gauthier; Jens C Pruessner
Journal:  Neuropsychol Rev       Date:  2014-08-13       Impact factor: 7.444

5.  Magnetic resonance imaging of the entorhinal cortex and hippocampus in mild cognitive impairment and Alzheimer's disease.

Authors:  A T Du; N Schuff; D Amend; M P Laakso; Y Y Hsu; W J Jagust; K Yaffe; J H Kramer; B Reed; D Norman; H C Chui; M W Weiner
Journal:  J Neurol Neurosurg Psychiatry       Date:  2001-10       Impact factor: 10.154

6.  The Goteborg MCI study: mild cognitive impairment is a heterogeneous condition.

Authors:  A Nordlund; S Rolstad; P Hellström; M Sjögren; S Hansen; A Wallin
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-11       Impact factor: 10.154

7.  Regional cerebral blood flow assessed with 99mTc-ECD SPET as a marker of progression of mild cognitive impairment to Alzheimer's disease.

Authors:  Marta Encinas; Ramón De Juan; Alberto Marcos; Pedro Gil; Ana Barabash; Cristina Fernández; Carmen De Ugarte; José Antonio Cabranes
Journal:  Eur J Nucl Med Mol Imaging       Date:  2003-08-15       Impact factor: 9.236

Review 8.  Psychiatric aspects of mild cognitive impairment.

Authors:  Elizabeth A Crocco; David A Loewenstein
Journal:  Curr Psychiatry Rep       Date:  2005-03       Impact factor: 8.081

9.  Mild cognitive impairment: an epidemiological perspective.

Authors:  Karen Ritchie
Journal:  Dialogues Clin Neurosci       Date:  2004-12       Impact factor: 5.986

10.  Age-related mild cognitive deficit: a ready-to-use concept?

Authors:  Christian Gilles
Journal:  Dialogues Clin Neurosci       Date:  2003-03       Impact factor: 5.986

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.